2026 Registered Companies

2048
46Health
Accreditation Council for Medical Affairs (ACMA)
AIF
Aisling Capital
Ajinomoto Group Ventures
Alira Health
Alpenglow Ventures LLC
Alykomed Global Solutions, LLC.
Ancilia Biosciences
AngelVest Fund LP
Asahi Kasei Therapeutics
AstraZeneca
Axia Discovery Inc.
Bayland Capital
Bench International
Bilix Co., Ltd
Biocytogen
Bioscience Equity Partners – Antisoma Venture Capital Fund
Biosion
Blue Matter
Bluezone Capital
Boehringer Ingelheim
Boston Capital Investment Club
Boston Harbor Angels
Bough Biosciences
Brothers Partners
BTB Therapeutics, Inc.
BTIG
Canaccord Genuity
Catalytic Impact Foundation
Champions Oncology
Chugai Venture Fund, LLC
Conceivable Life Sciences
Concr
Consano Bio
Covenant Venture Capital
CR Ventures
Curie Capital
Daiichi Sankyo, Inc.
Danforth Health
Department of Veterans Affairs
Desire Ventures Inc.
DLH Corporation
EGB
EisnerAmper
Eos BioInnnovation
Epidarex Capital
Epion Therapeutics, Inc.
Epitome Therapeutics
Eratos Therapeutics
ESC Advisors
Esham Strategies
Evotec
EW Healthcare Partners
Eyedaptic
Ferghana Partners
Foley Hoag
FoxHill Asset Management
Fractal Pediatric Capital
Gachon University
Galimedix Therapeutics, Inc.
Garland Surgical Ltd
GemPharmatech

Gilga-Med, Inc.
Globivest
GOA Therapeutics
Golden Seeds
Guidant BioTherapeutics
High Cape Capital CapeHaven
Hogan Lovells Cadwalader
HumanFactor Capital LLC
IKJ Capital
Imbolc Partners
Imessa Research Inc.
ImmuneOnco Biopharmaceuticals
Immunis, Inc.
Immunophotonics, Inc.
ITR Laboratories
JLS Fund
Johnson & Johnson
JonesTrading Institutional Services, LLC
Journalist & Entrepreneur
K2X and US Angels
KdT Ventures
Kerna Ventures
KPMG LLP
Lake Street Capital Markets
Laplace Partners
LD, LLC
Litmys, LLC
LongeVC
Lonza
Lowenstein Sandler LLP
Luma Group
LvlUp Ventures
MaidStone Life Sciences
Maruho Co., Ltd.
Mayo Clinic
McKinsey & Company
Med Academy Sweden AB
Melior Capital Management
Memorial Sloan Kettering Cancer Center
Mesenbio Ltd
Midsized Biotech Alliance of America (MBAA)
Mizuho Securities USA LLC
MolAIcule, Inc.
MycaZED Therapeutics
Myosin Therapeutics
NCBiotech
Network Bio
Neutargeton Therapeutics
New York Angels
NewYorkBIO
Nexeption Capital
Niche Pharmaceuticals , Inc.
Nissan Chemical America Corporation
NJ Angels
Nkarta
No Patient Left Behind (NPLB)
Nona Biosciences
NSIP LLC
OBIO
Oncore Venture
Oncoustics
Open Door Salon
Orbit Genomics, Inc.
Origami Therapeutics, Inc.

Osage University Partners
Oxford Science Enterprises
Panacea Venture
panluminate, Inc.
Particles for Humanity
Perseo Pharma AG
Phare Bio
PharmCube
Phase Capital
Piper Sandler
Playground Global
Plug and Play Japan
Prevail Partners LLC
Princeton Alumni Angels
PriveBio
PTM Therapeutics, Inc.
Quadlytics Inc.
Quantflow
Quench Medical
Rakuten Medical
RCP Venture Capital
ReadHealthy Communications
Reagan-Udall Foundation
Reflector Bio
Rege Nephro Co., Ltd.
Regeneron Pharmaceuticals, Inc.
Reglagene, Inc.
Repairon Immuno
Rhythm VC / CP
Riboway Therapeutics
Rizk Management Advisors
Rodman & Renshaw, LLC
Russo Partners
Saghmos Therapeutics
Schrödinger
Scientific American
Scrum Ventures
SGS Pharma
She’s Independent Investments
Stanford University
Starton Therapeutics
STEMCELL Technologies
Syneos Health
Synthis Therapeutics, Inc.
Taiwania Capital
Talfinium Investments Inc.
TG Ventures | TG Therapeutics, Inc.
The Venture Collective (TVC)
Thermo Fisher Scientific
Trinity Financing Investments Corporation
Turn Therapeutics Inc.
Two Bear Capital
United Therapeutics Corp
Vast Therapeutics
WARF Ventures
WBB Securities
Wharton Alumni Angels
WHITE TIGER GROUND
William Blair
Withum
WuXi AppTec
Xontogeny
zebraMD